News
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the third patient in Cohort 4 of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback